Note: Ingredients listed on restricted chemical lists
EC/CAS
64742-96-7
Name of the chemical
Solvent naphtha (petroleum), heavy aliph
Concentration
N/A
EC/CAS
106-97-8
Name of the chemical
n-Butan, enthält 0,1% Butadien
Concentration
N/A
EC/CAS
64742-65-0
Name of the chemical
Distillates (petroleum), solvent-dewaxed heavy paraffinic
Concentration
N/A
EC/CAS
111-76-2
Name of the chemical
Ethylene glycol monobutyl ether (EGBE)
Concentration
N/A
General Information
Product name
ESP (Aerosol)
Product Synonyms
NF
supplier name
Gesswein
Icons in SDS
Company Information
company name
Gesswein
Section 2
SECTION 2: Hazards identification
EMERGENCY OVERVIEW * * *
Principle Routes of Exposure
Target Organs HMIS Skin and inhalation NF H-2 F-2 R-0 PPE-see Sect. VIII ACUTE EFFECTS Inhalation: Excessive inhalation of vapors can cause nasal and respiratory irritation, central nervous system effects include dizziness, weakness, headache, possible unconsciousness and even death. Eye: Can cause severe irritation, redness, tearing and blurred vision. Skin: Prolonged or repeated contact can cause moderate irritation, defatting and dermatitis. Component is readily absorbed through the skin and may produce toxic effects. Ingestion: Can cause gastrointestinal irritation, nausea, vomiting and diarrhea. Aspiration of material into the lungs can cause chemical pneumonitis which can be fatal. Carcinogenicity IARC, NTP, and OSHA do not list ESP (Aerosol) as a carcinogen.
Medical Conditions Generally Aggravated by Exposure
NF
Potential chronic health
Overexposure to one of the components has apparently been found to cause the following in laboratory animals: anemia, liver abnormalities, kidney damage, lung damage and blood abnormalities.
